PRDX6 and ovarian carcinoma: Immunoblotting analysis showed that overexpression of PRDX6 obviously promoted the activation of MAPK signaling pathway in ovarian cancer cells, as evidenced by increased phosphorylation levels of extracellular signal‐regulated kinase (ERK), c‐Jun N‐terminal kinase (JNK), and p38 (Figure 5M).